Cargando…
Trends in clinical development of pediatric cancer for PD-1 and PD-L1 inhibitors: an analysis of ClinicalTrials.gov
Compared with cytotoxic chemotherapy, radiotherapy, and surgery, positive findings have been acquired through the approach of blocking the programmed cell death protein 1 (PD-1) pathway with antibodies that exert inhibitory effects on PD-1 or cell death protein ligand 1 (PD-L1). Results from clinica...
Autores principales: | Que, Yi, Hu, Yang, Hong, Dongchun, Zhang, Yizhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479973/ https://www.ncbi.nlm.nih.gov/pubmed/34583971 http://dx.doi.org/10.1136/jitc-2021-002920 |
Ejemplares similares
-
Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.gov
por: Dai, Zelei, et al.
Publicado: (2023) -
Characteristics of pediatric pulmonary hypertension trials registered on ClinicalTrials.gov
por: Awerbach, Jordan D., et al.
Publicado: (2017) -
Trends in US pediatric mental health clinical trials: An analysis of ClinicalTrials.gov from 2007–2018
por: Wortzel, Joshua R., et al.
Publicado: (2021) -
Characteristics of Depression Clinical Trials Registered on ClinicalTrials.gov
por: Liang, Juan, et al.
Publicado: (2022) -
Some data quality issues at ClinicalTrials.gov
por: Chaturvedi, Neha, et al.
Publicado: (2019)